Pages Navigation Menu

Illuminating Pathways To a Healthy Brain

New Science Counters Ketamine Critics, Showing Depression is Relieved

Neuro-Luminance Brain Health Centers, Inc. is proud to announce the latest science shows ketamine infusion can effectively treat depression, according to a new study published today by the peer-reviewed journal Neural Regeneration Research. Conducted and authored by our own co-founder Dr. Theodore Henderson, the study gives “real world” experience treating many patients with ketamine, and allays related fears. His findings, effective with patients nearly 80% of the time, stand in direct contrast to warnings from the American Psychiatric Association (APA). Read the news and study here. This should not alarm anyone. In fact, the opposite should be true. This scientific study is the latest research performed on ketamine, written to give people suffering with depression a reason to ask their doctors, or get more information, find answers and get the help they need. Depression is not to be taken lightly....

Read More

Adolescent football: Not as safe as you may think

Concussions have been in the limelight recently due to the deaths of high profile professional athletes who experienced repeated hits to their head. This information has created heightened attention for prevention, diagnosis and treatment for concussions in children and adolescents participating in sports.  According to the Centers for Disease Control and Prevention (CDC), 173,285 patients 19 years and younger are treated in the emergency room each years for sports and recreational traumatic brain injuries, which includes concussions. This number has increased by 60% in the past decade among those playing football, soccer, hockey and other contact sports. Even though professional football has been the most researched group of professional athletes when it comes to brain changes from hits to the head, they are a very small subset of people who play football overall.  Seventy percent of football players are...

Read More

Suicide among veterans of the United States military

Suicide among veterans of the United States military is an ongoing phenomenon with 23 veterans committing suicide every day. This translates to a suicide every 65 minutes.   Between 2007 and 2010, the number of deaths from suicide in the U.S. increased by nearly 11%. Annual suicide rates among U.S. adults aged 35 to 64 increased from 13.7 to 17.6 suicides per 100,000 people between 1999 and 2010. Rates of suicide among middle-age men in the general population have increased during the past three years. Suicide rates among those aged 50-54 years increased by 48 percent, while for those aged 55-59 years increased by 49 percent. An interesting statistic is the fact that the rate of suicide in women jumped higher (32 %) compared to that of men (27 %).   The most alarming thing is that these figures...

Read More

Is Clinical Diagnosis of Parkinson’s disease (IPD) Enough?

Still, some clinicians argue that their clinical diagnosis is sufficient. However, two considerations are worth noting. First, Walker and colleagues (J Neurol Neurosurg Psychiatry. 2007;78:1176-1181) demonstrated that the specificity of clinical diagnosis was considerably lower than that of DaTSCAN. Sensitivity of clinical diagnosis and DaTSCAN were similar at about 85%; however, specificity of DaTSCAN was 86% and that of clinical examination was only 50%. One example of a clinically deceptive situation is psychogenic or pharmacological tremor, which can be confused with IPD, leading to unnecessary treatment. Second, the other parkinsonian syndromes, such as Lewy Body Dementia, can initially look clinically indistinguishable from IPD. DaTSCAN gives much more of a differentiation. Using quantitative analysis can greatly enhance the diagnostic potential of DaTSCAN. A Superior Way to Differentiate Classically, IPD can present with asymmetry in the loss of dopamine reuptake sites,...

Read More

US Autism & Asperger Association 9th Annual World Conference

Dr. Theodore Henderson of Neuro-Luminance will be presenting at the United States Autism and Asperger Association (USAAA) meeting this month. The USAAA meeting held in Kansas City, Missouri from September 4-7, 2014 is designed for persons with autism, their families and their clinicians. Dr. Henderson will be speaking on the psychopharmacology of comorbid conditions associated with autism. He will be integrating neuroimaging, sophisticated pharmacology, and a deep understanding of how the brain functions. In addition, he will be featured on professional panels on many aspects of autism. The entire USAAA conference, including Dr. Henderson’s talks will be recorded and available on the USAAA...

Read More